Skyrizi 150 mg solution for injection in pre-filled pen

Company
AbbVie Limited
Active Ingredient
Strength
  • Risankizumab: 150 mg
Dosage Form
Solution for injection in pre- filled pen
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026
Licence Info section shown.
Licence numbers with strength, ATC code and dosage form
Licence number Strength ATC Code Dosage Form
EU/1/19/1361/002 150 mg L04AC18 Solution for injection in pre- filled pen
Licence number
EU/1/19/1361/002
Strength
150 mg
ATC Code
L04AC18
Dosage Form
Solution for injection in pre- filled pen

AbbVie Limited

Citywest Business Campus, Dublin 24, Ireland